| API and intermediates |
| Products |
CAS No. |
Usage |
 Diabetes |
 (R)-3-piperidinamine dihydrochloride |
334618-23-4 |
Alogliptin intermediate |
| 6-Chloro-3-methyluracil |
4318-56-3 |
Alogliptin intermediate |
| 6-Chlorouracil |
4270-27-3 |
Alogliptin intermediate |
| 2-[(6-Chloro-3,4-dihydro-3-Methyl-2,4-dioxo-1(2h)-pyriMidinyl)Methyl]benzonitrile |
865758-96-9 |
Alogliptin intermediate |
| Alogliptin |
850649-61-5 |
Alogliptin |
| Alogliptin Benzoate |
850649-62-6 |
Alogliptin Benzoate |
| 1,2-Diamino-2-methylpropane |
811-93-8 |
Anagliptin intermediate |
| 2-Methyl-1,2-propanediamine dihydrochloride |
15444-85-6 |
Alogliptin intermediate |
| 2-Methylpyrazolo[1,5-a]pyriMidine-6-carboxylic acid |
739364-95-5 |
Anagliptin intermediate |
| (2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile |
207557-35-5 |
Anagliptin intermediate |
| 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone |
32384-65-9 |
Canagliflozin intermediate |
| (5-bromo-2-Methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)Methanone |
1132832-75-7 |
Canagliflozin intermidate |
| 2-(5-bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene |
1030825-20-7 |
Canagliflozin intermediate |
| (5-(4-Fluorophenyl)thiophen-2-yl)(5-iodo-2-Methylphenyl)Methanone |
1071929-08-2 |
Canagliflozin intermidate |
| 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene |
898566-17-1 |
Canagliflozin intermediate |
| Methyl 1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucopyranoside |
1030825-21-8 |
Canagliflozin intermediate |
| (1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol tetraacetate |
866607-35-4 |
Canagliflozin intermidate |
| Canagliflozin |
842133-18-0 |
Canagliflozin |
| Canagliflozin Hemihydrate |
928672-86-0 |
Canagliflozin Hemihydrate |
| 2,3,4,6-Tetra-O-pivaloyl-alpha-D-glucopyranosyl bromide |
81058-27-7 |
Dapagliflozin intermediate |
| 5-bromo-2-chlorobenzoic acid |
21739-92-4 |
Dapagliflozin intermediate |
| (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone |
461432-22-4 |
Dapagliflozin intermediate |
| 5-bromo-2-chloro-4’-ethoxydiphenylmethane |
461432-23-5 |
Dapagliflozin intermediate |
| Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-alpha-D-glucopyranoside |
714269-57-5 |
Dapagliflozin intermediate |
| (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate |
461432-25-7 |
Dapagliflozin intermediate |
| 2-Chloro-5-iodobenzoic acid |
19094-56-5 |
Dapagliflozin intermediate |
| (5-Iodo-2-chlorophenyl)(4-ethoxyphenyl)methanone |
1103738-26-6 |
Dapagliflozin intermediate |
| 4-Iodo-1-chloro-2-(4-ethoxybenzyl)benzene |
1103738-29-9 |
Dapagliflozin intermediate |
| Dapagliflozin |
461432-26-8 |
Dapagliflozin |
| Dapagliflozin propanediol monohydrate |
960404-48-2 |
Dapagliflozin propanediol monohydrate |
| 4-[(5-Bromo-2-chlorophenyl)methyl]phenol |
864070-18-8 |
Empagliflozin intermediate |
| (R)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate |
219823-47-9 |
Empagliflozin intermediate |
| (5-Bromo-2-chlorophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone |
915095-84-0 |
Ipragliflozin intermidate |
| (5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone |
915095-85-1 |
Empagliflozin intermediate |
| (3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]tetrahydrofuran |
915095-89-5 |
Empagliflozin intermediate |
| (2S,3R,4S,5S,6R)-2-(3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol |
1279691-36-9 |
Empagliflozin intermediate |
| (2-Chloro-5-iodophenyl)(4-fluorophenyl)methanone |
915095-86-2 |
Empagliflozin intermediate |
| (2-Chloro-5-iodophenyl)[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methanone |
915095-87-3 |
Empagliflozin intermediate |
| (3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan |
915095-94-2 |
Empagliflozin intermediate |
| (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol tetraacetate |
915095-99-7 |
Empagliflozin intermidate |
| Empagliflozin |
864070-44-0 |
Empagliflozin |
| Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside |
1528636-39-6 |
Ertugliflozin intermidate |
| Ertugliflozin |
1210344-57-2 |
Ertugliflozin |
| Ertugliflozin L-pyroglutamic acid |
1210344-83-4 |
Ertugliflozin L-pyroglutamic acid |
| 2-Fluoro-5-Bromobenzaldehyde |
93777-26-5 |
Ipragliflozin intermediate |
| 2-(5-Bromo-2-fluorobenzyl)benzothiophene |
1034305-17-3 |
Ipragliflozin intermediate |
| Ipragliflozin |
761423-87-4 |
Ipragliflozin |
| Ipragliflozin L-proline |
951382-34-6 |
Ipragliflozin L-proline |
| (R)-3-(Boc-Amino)piperidine |
309956-78-3 |
Linagliptin intermediate |
| (S)-3-N-Boc-aminopiperidine |
216854-23-8 |
Linagliptin intermediate |
| 8-Bromo-3-methyl-xanthine |
93703-24-3 |
Linagliptin intermediate |
| 1-Bromo-2-butyne |
3355-28-0 |
Linagliptin intermediate |
| 8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione |
666816-98-4 |
Linagliptin intermediate |
| 2-(chloromethyl)-4-methylquinazoline |
109113-72-6 |
Linagliptin intermediate |
| 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione |
853029-57-9 |
Linagliptin intermidate |
| Boc Linagliptin |
668273-75-4 |
Linagliptin intermidate |
| Linagliptin |
668270-12-0 |
Linagliptin |
| Boc-3-Hydroxy-1-adamantyl-D-glycine |
361442-00-4 |
Saxagliptin intermediate |
| (1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester |
361440-67-7 |
Saxagliptin intermediate |
| (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide mesylate |
709031-45-8 |
Saxagliptin intermediate |
| Saxagliptin hydrate |
945667-22-1 |
Saxagliptin hydrate |
| Saxagliptin hydrochloride |
709031-78-7 |
NA |
| (5S)-4,5-O-(1-Methylethylidene)-1-C-4-morpholinyl-D-xylo-pentodialdo-5,2-furanose |
1103738-19-7 |
Sotagliflozin intermidate |
| (5S)-1-C-[4-Chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-4,5-O-(1-methylethylidene)-D-xylo-pentodialdo-5,2-furanose |
1103738-30-2 |
Sotagliflozin intermidate |
| Sotagliflozin |
1018899-04-1 |
Sotagliflozin |
| Boc-(R)-3-Amino-4-(2,4,5-trifluorophenyl)butanoic acid |
486460-00-8 |
Sitagliptin intermidate |
| 3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride |
762240-92-6 |
Sitagliptin intermidate |
| (2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester |
401564-36-1 |
Teneligliptin intermediate |
| Teneligliptin |
760937-92-6 |
Teneligliptin |
| Teneligliptin Hydrobromide |
906093-29-6 |
Teneligliptin Hydrobromide |
| Teneligliptin hydrobromide hydrate (2:5)X H2O |
1572583-29-9 |
Teneligliptin hydrobromide hydrate (2:5)X H2O |
| 2-CYANO-5-FLUOROBENZYL BROMIDE |
421552-12-7 |
Trelagliptin (SYR472) intermediate |
| Trelagliptin |
865759-25-7 |
Trelagliptin |
| Trelagliptin succinate |
1029877-94-8 |
Trelagliptin (SYR472) succinate |
| 2,3,4,6-Tetra-O-benzyl-D-glucono-1,5-lactone |
13096-62-3 |
Tofogliflozin intermediate |
| 2-Bromoterephthalic acid |
586-35-6 |
Tofogliflozin intermediate |
| L-Prolinamide |
7531-52-4 |
Vildagliptin intermediate |
| D-Prolinamide |
62937-45-5 |
Vildagliptin intermediate |
| 3-Amino-1-adamantanol |
702-82-9 |
Vildagliptin intermediate |
| Antiviral |
| 3-Benzyloxy-4-oxo-4H-pyran-2-carboxylic acid |
119736-16-2 |
Baloxavir intermediate |
| 3-Benzyloxy-4-oxo-4H-pyran-2-carboxylic acid methyl ester |
1332855-89-6 |
NA |
| (12aR)-3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
1985607-70-2 |
Baloxavir intermediate |
| 7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol |
1985607-83-7 |
Baloxavir intermediate |
| 3,4,12,12a-Tetrahydro-7-(phenylmethoxy)-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione |
1370250-39-7 |
Balochavir intermediate |
| Chloromethyl methyl carbonate |
40510-81-4 |
Baloxavir intermediate |
| 7,8-Difluoro-dibenzo[b,e]thiepin-11(6H)-one |
2136287-66-4 |
Baloxavir intermediate |
| 3,4-DIFLUORO-2-METHYLBENZOIC ACID |
157652-31-8 |
Baloxavir intermediate |
| Baloxavir |
1985605-59-1 |
Baloxavir |
| Baloxavir marboxil |
1985606-14-1 |
Baloxavir marboxil |
| 3-Aminocyclopentanol hydrochloride |
1184919-69-4 |
GS9883/Bictegravir intermidate |
| (1R,3S)-3-Aminocyclopentanol |
1110772-05-8 |
Bictegravir intermediate |
| (1R,3S)-3-Aminocyclopentanol hydrochloride |
1279032-31-3 |
Bictegravir intermediate |
| 2,4,6-Trifluorobenzonitrile |
96606-37-0 |
GS9883/Bictegravir intermediates |
| 2,4,6-Trifluorobenzylamine |
214759-21-4 |
Bictegravir intermediate |
| Bictegravir |
1611493-60-7 |
Bictegravir |
| Bictegravir Sodium |
1807988-02-8 |
Bictegravir Sodium |
| Phenyl hydrogen [(R)-1-(6-amino-9H-purin-9-yl)propan-2-yloxy]methylphosphonate |
379270-35-6 |
Tenofovir alafenamide intermidate |
| Tenofovir alafenamide |
379270-37-8 |
Tenofovir alafenamide |
| Tenofovir alafenamide Hemi-fumarate |
1392275-56-7 |
Tenofovir alafenamide Hemi-fumarate |
| Tenofovir alafenamide fumarate |
379270-38-9 |
Tenofovir alafenamide fumarate |
| Antitumor |
| (3-Chloropyrazin-2-yl)MethanaMine hydrochloride |
939412-86-9 |
Acalabrutinib intermidate |
| 3-Chloropyrazin-2-methanamine dihydrochloride |
867165-53-5 |
Acalabrutinib intermediate |
| (S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate |
1420478-88-1 |
Acalabrutinib intermidate |
| N-Pyridin-2-yl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide |
1383385-64-5 |
Acalabrutinib intermidate |
| 4-(PYRIDIN-2-YL)AMINOCARBONYLPHENYLBORONIC ACID |
850568-25-1 |
Acalabrutinib intermidate |
| 4-[8-Amino-3-(2S)-2-pyrrolidinylimidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide |
1420478-90-5 |
Acalabrutinib intermediate |
| Acalabrutinib /ACP-196 |
1420477-60-6 |
Acalabrutinib /ACP-196 |
| (S)-(+)-3-Hydroxytetrahydrofuran |
86087-23-2 |
Afatinib intermediate |
| (R)-(-)-3-Hydroxytetrahydrofuran |
86087-24-3 |
Afatinib intermediate |
| Trans-4-Dimethylaminocrotonic acid hydrochloride |
848133-35-7 |
Afatinib intermediate |
| 7-Fluoro-6-nitro-4-hydroxyquinazoline |
162012-69-3 |
Afatinib intermediate |
| Afatinib |
439081-18-2/850140-72-6 |
Afatinib |
| Afatinib Dimaleate |
850140-73-7 |
Afatinib Dimaleate |
| 2-(Dimethylphosphinyl)benzenamine |
1197953-47-1 |
Brigatinib intermidate |
| 2,5-dichloro-N-(2-(diMethylphosphoryl)phenyl)pyriMidin-4-aMine |
1197953-49-3 |
Brigatinib intermidate |
| 1-[1-(3-methoxy-4-nitro-phenyl)-piperidin-4-yl]-4-methyl-piperazine |
761440-65-7 |
Brigatinib intermidate |
| [2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine |
761440-75-9 |
Brigatinib intermidate |
| Brigatinib |
1197953-54-0 |
Brigatinib |
| (aR,3aS,4S,6S,7aR)-Hexahydro-3a,8,8-trimethyl-alpha-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole-2-methanamine 2,2,2-trifluoroacetate |
179324-87-9 |
Bortezomib intermidate |
| N-(2-Pyrazinylcarbonyl)-L-phenylalanine |
114457-94-2 |
Bortezomib intermidate |
| Bortezomib |
179324-69-7 |
Bortezomib intermidate |
| 3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole |
330792-70-6 |
Ibrutinib intermediate |
| 5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMine(N-2) |
330786-24-8 |
Ibrutinib intermediate |
| (S)-1-Boc-3-hydroxypiperidine |
143900-44-1 |
Ibrutinib intermediate |
| (R)-tert-Butyl 3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carboxylate (N-1) |
1022150-11-3 |
Ibrutinib intermediate |
| 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine |
1022150-12-4 |
Ibrutinib intermediate |
| Ibrutinib |
936563-96-1 |
Ibrutinib |
| 2-(2,5-Dichlorobenzamido)acetic acid |
667403-46-5 |
Ixazomib (MLN9708)Intermediate |
| Ixazomib |
1072833-77-2 |
Ixazomib |
| Ixazomib Citrate |
1201902-80-8 |
Ixazomib (MLN9708) Citrate |
| Ixazomib citrate (USAN) |
1239908-20-3 |
Ixazomib citrate (USAN) |
| 4-Amino-3-chlorophenol |
17609-80-2 |
Lenvatinib Intermediate |
| 4-Amino-3-chlorophenol hydrochloride |
52671-64-4 |
Lenvatinib intermediate |
| N-(2-Chloro-4-hydroxyphenyl)-N’-cyclopropyl-urea |
796848-79-8 |
Lenvatinib intermediate |
| 1,4-Dihydro-7-methoxy-4-oxo-6-quinolinecarboxylic acid methyl ester |
205448-65-3 |
Lenvatinib intermidate |
| Methyl 4-chloro-7-methoxyquinoline-6-carboxylate |
205448-66-4 |
Lenvatinib intermidate |
| 4-Chloro-7-methoxyquinoline-6-carboxamide |
417721-36-9 |
Lenvatinib intermidate |
| Lenvatinib |
417716-92-8 |
Lenvatinib |
| Lenvatinib mesylate |
857890-39-2 |
Lenvatinib mesylate |
| 3-Hydroxyisobenzofuran-1(3h)-one |
16859-59-9 |
Olaparib (AZD2281) intermediate |
| 3-Oxo-1,3-dihydroisobenzofuran-1-ylphosphonic acid |
61260-15-9 |
Olaparib (AZD2281) intermediate |
| 2-FLUORO-5-FORMYLBENZONITRILE |
218301-22-5 |
Olaparib (AZD2281) intermediate |
| 2-Fluoro-5-[(3-oxo-1(3H)-isobenzofuranylidene)methyl]-benzonitrile |
763114-25-6 |
Olaparib (AZD2281) intermediate |
| 2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile |
1021298-68-9 |
Olaparib (AZD2281) intermediate |
| 2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoic acid |
763114-26-7 |
Olaparib Intermediate (AZD2281) |
| Tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate |
414910-15-9 |
Olaparib (AZD2281) intermediate |
| 1-(Cyclopropylcarbonyl)piperazine |
59878-57-8 |
Olaparib (AZD2281) intermediate |
| 1-(cyclopropylcarbonyl)-, Monohydrochloride |
1021298-67-8 |
Olaparib (AZD2281) intermediate |
| 1-[5-[(3,4-Dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine |
763111-47-3 |
Olaparib intermediate |
| Olaparib |
763113-22-0 |
Olaparib (AZD2281) |
| 4-Fluoro-2-methoxy-5-nitroaniline |
1075705-01-9 |
Osimertinib (AZD9291) intermediate |
| 3-(2-Chloropyrimidin-4-yl)-1-meth ylindole |
1032452-86-0 |
Osimertinib(AZD9291) intermediate |
| N,N,N’-TRIMETHYLETHYLENEDIAMINE |
142-25-6 |
Osimertinib (AZD9291) intermediate |
| N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]-1,2,4-benzenetriamine |
1421372-66-8 |
Osimertinib intermediates |
| Osimertinib |
1421373-65-0 |
Osimertinib (AZD9291) |
| Osimertinib mesylate |
1421373-66-1 |
Osimertinib mesylate |
| 6-(Chloromethyl)uracil |
18592-13-7 |
Tipiracil+Trifluridine/TAS-102 intermediate |
| 2-AMINO-1-PYRROLINE HYDROCHLORIDE |
7544-75-4 |
Tipiracil+Trifluridine/TAS-102 intermediate |
| 5-(Trifluoromethyl)uracil |
54-20-6 |
Tipiracil+Trifluridine/TAS-102 intermediate |
| Trifluridine |
70-00-8 |
Trifluridine |
| Cardiovascular |
| Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate |
27143-07-3 |
Apixaban intermidate |
| Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]ethanoate |
473927-63-8 |
Apixaban intermidate |
| 1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1H)-pyridinone |
1267610-26-3 |
Apixaban intermidate |
| 1-(4-IODO-PHENYL)-PIPERIDIN-2-ONE |
385425-15-0 |
Apixaban intermidate |
| 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one |
536760-29-9 |
Apixaban intermidate |
| 3-(Morpholin-4-yl)-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one |
503615-03-0 |
Apixaban intermidate |
| 3-Morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1H-pyridin-2-one |
545445-44-1 |
Apixaban intermidate |
| 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester |
536759-91-8 |
Apixaban intermidate |
| 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester |
503614-91-3 |
Apixaban intermidate |
| Apixaban |
503612-47-3 |
Apixaban |
| 2-Nitro-5-methoxybenzoic acid |
1882-69-5 |
Betrixaban intermidate |
| 2-Amino-5-methoxybenzoic acid |
6705-03-9 |
Betrixaban intermidate |
| Betrixaban |
330942-05-7 |
Betrixaban |
| Betrixaban Maleate |
936539-80-9 |
Betrixaban Maleate |
| 2-THIOADENOSINE |
43157-50-2 |
Cangrelor intermediate |
| CLODRONIC ACID |
10596-23-3 |
Cangrelor Intermediate |
| CLODRONIC ACID N-BUTYLAMINE SALT |
163706-61-4 |
Cangrelor intermediate |
| 2-CHLOROETHYL METHYL SULFIDE |
542-81-4 |
Cangrelor intermediate |
| (2R,3R,4S,5R)-2-(6-aMino-2-(3,3,3-trifluoropropylthio)-9H-purin-9-yl)-5-(hydroxyMethyl)tetrahydrofuran-3,4-diol |
163706-51-2 |
Cangrelor intermediate |
| (2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol |
163706-58-9 |
Cangrelor intermediate |
| Cangrelor base |
163706-06-7 |
Cangrelor base |
| Cangrelor tetrasodium |
163706-36-3 |
Cangrelor tetrasodium |
| 4,5,6,7-tetrahydro-5-Methyl-Thiazolo[5,4-c]pyridin |
720720-96-7 |
Edoxaban intermediate |
| [(5-Chloro-2-pyridinyl)amino]oxoacetic acid |
552850-73-4 |
Edoxaban intermediate |
| N-(5-chloro-pyridin-2-yl)-oxalamic acid ethyl ester |
349125-08-2 |
Edoxaban intermediate |
| 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride |
1243308-37-3 |
Edoxaban intermediate |
| (S)-(-)-3-Cyclohexenecarboxylic acid |
5708-19-0 |
Edoxaban intermediate |
| (1S,3R,4R)-3-(Boc-aMino)-4-hydroxy-cyclohexanecarboxylic acid ethyl ester |
365997-33-7 |
Edoxaban intermediate |
| (1S,3S,6R)-N,N-dimethyl-7-oxabicyclo[4.1.0]heptane-3-carboxamide |
929693-35-6 |
Edoxaban intermidate |
| Tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate |
365998-36-3 |
Edoxaban Intermediate |
| Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate oxalic acid |
1210348-34-7 |
Edoxaban intermediate |
| Tert-Butyl(1R,2S,5S)-2-azido-5-[(dimethylamino)carbonyl]cyclohexylcarbamate oxalic acid monohydrate |
1353893-22-7 |
Edoxaban intermediate |
| Edoxaban |
480449-70-5 |
Edoxaban |
| Edoxaban tosylate |
480449-71-6/912273-65-5 |
Edoxaban tosylate |
| Edoxaban tosylate monohydrate |
1229194-11-9 |
Edoxaban tosylate monohydrate |
| 5-Isoquinolinesulfonic acid |
27655-40-9 |
Fasudil HCl intermidate |
| ISOQUINOLINE-5-SULFONYL CHLORIDE |
84468-15-5 |
Fasudil HCl intermidate |
| Isoquinoline-5-sulphonyl chloride hydrochloride |
105627-79-0 |
Fasudil HCl intermidate |
| Homopiperazine |
505-66-8 |
Fasudil HCL 中间体 |
| FASUDIL |
103745-39-7 |
Fasudil |
| Fasudil HCl |
105628-07-7 |
Fasudil HCl |
| (R)-tert-butyl-(1-([1,1’-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate |
1426129-50-1 |
Sacubitril/AHU-377 /LCZ696 intermediate |
| (R,E)-5-([1,1’-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid |
1012341-48-8 |
Sacubitril/ AHU-377/LCZ696 intermediate |
| (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-50-2 |
Sacubitril/ AHU-377 /LCZ696 intermediate |
| (2R,4S)-4-Amino-5-(biphenyl-4-yl)-2-methylpentanoic acid ethyl ester hydrochloride |
149690-12-0 |
Sacubitril/AHU-377 /LCZ696 Intermediate |
| Sacubitril |
149709-62-6 |
Sacubitril/ AHU -377/ LCZ696 |
| AHU-377 hemicalcium salt （2:1） |
1369773-39-6 |
AHU-377 hemicalcium salt （2:1） |
| LCZ696 |
936623-90-4 |
LCZ696 |
| 5-Chloro-2-thiophenecarboxylic acid |
24065-33-6 |
Rivaroxaban intermediate |
| 5-Chlorothiophene-2-carbonyl chloride |
42518-98-9 |
Rivaroxaban intermidate |
| 4-(4-aminophenyl)morpholin-3-one |
438056-69-0 |
Rivaroxaban intermediate |
| (S)-(+)-N-(2,3-Epoxypropyl)phthalimide |
161596-47-0 |
Rivaroxaban intermediate |
| 2-[(2R)-2-HYDROXY-3-[[4-(3-OXO-4-MORPHOLINYL)PHENYL]AMINO]PROPYL]-1H-ISOINDOLE-1,3(2H)-DIONE |
446292-07-5 |
Rivaroxaban intermediate |
| 2-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl} |
446292-08-6 |
Rivaroxaban intermediate |
| 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone hydrochloride |
898543-06-1 |
Rivaroxaban intermediate |
| Rivaroxaban |
366789-02-8 |
Rivaroxaban |
| 5-Chloro-2,3-diphenylpyrazine |
41270-66-0 |
Selexipag intermediate |
| 4-[(1-Methylethyl)amino]-1-butanol |
42042-71-7 |
Selexipag intermediate |
| 4-[(5,6-Diphenylpyrazinyl)(1-methylethyl)amino]-1-butanol |
475086-75-0 |
Selexipag intermediate |
| Selexipag |
475086-01-2 |
Selexipag |
| Other categories |
| 4-Chloropyrrolo[2,3-d]pyrimidine |
3680-69-1 |
Baricitinib intermediate |
| 4-Chloro-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine |
941685-26-3 |
Baricitinib intermediate |
| 1-(1-Ethoxyethyl)-1H-pyrazole-4-boronic acid pinacol ester |
1029716-44-6 |
Baricitinib intermediate |
| 4-(1H-Pyrazol-4-yl)-7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2,3-d]pyrimidine |
941685-27-4 |
Baricitinib intermediate |
| Tert-Butyl 3-oxoazetidine-1-carboxylate |
398489-26-4 |
Baricitinib intermediate |
| 3-(Cyanomethylene)-1-azetidinecarboxylic acid tert-butyl ester |
1153949-11-1 |
Baricitinib intermediate |
| 2-[1-(Ethylsulfonyl)-3-azetidinylidene]acetonitrile |
1187595-85-2 |
Baricitinib intermediate |
| (4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate |
1187595-90-9 |
Baricitinib intermediate |
| Baricitinib |
1187594-09-7 |
Baricitinib |
| Baricitinib phosphate salt |
1187595-84-1 |
Baricitinib phosphate salt |
| 3-benzyl-6-bromo-2-chloroquinoline |
654655-68-2 |
Bedaquiline intermediate |
| 3-Benzyl-6-bromo-2-methoxyquinoline |
654655-69-3 |
Bedaquiline intermediate |
| 3-(Dimethylamino)-1-(naphthalen-1-yl)propan-1-one |
10320-49-7 |
Bedaquiline intermediate |
| 3-Dimethylamino-1-(naphthalen-1-yl)propan-1-one hydrochloride |
5409-58-5 |
Bedaquiline intermediate |
| (R)-(-)-1,1’-Binaphthyl-2,2’-diyl hydrogenphosphate |
39648-67-4 |
Bedaquiline intermediate |
| Bedaquiline |
843663-66-1 |
Bedaquiline |
| Bedaquiline fumarate |
845533-86-0 |
Bedaquiline fumarate |
| 2-Bromo-5-hydroxybenzaldehyde |
2973-80-0 |
Crisaborole （AN-2728 intermediate |
| 4-[4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy]benzonitrile |
1217366-74-9 |
Crisaborole （AN-2728）intermediate |
| 4-(4-Bromo-3-formylphenoxy)benzonitrile |
906673-54-9 |
Crisaborole （AN-2728）intermediate |
| 4-[4-Bromo-3-(hydroxymethyl)phenoxy]benzonitrile |
906673-45-8 |
Crisaborole （AN-2728）intermediate |
| 4-(3-Formylphenoxy)benzonitrile |
90178-72-6 |
Crisaborole （AN-2728）intermediate |
| Crisaborole |
906673-24-3 |
Crisaborole （AN-2728） |
| (5S)-5-Phenyl-2-morpholinone hydrochloride |
491833-36-4 |
Eliglustat intermediate |
| 1,4-Benzodioxane-6-carboxaldehyde |
29668-44-8 |
Eliglustat intermediate |
| (1R,3S,5S,8aS)-1,3-Bis(2,3-dihydro-1,4-benzodioxin-6-yl)tetrahydro-5-phenyl-3H,8H-oxazolo[4,3-c][1,4]oxazin-8-one |
491833-25-1 |
Eliglustat intermediate |
| 1-[(2S,3R)-3-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-hydroxy-2-[[(1S)-2-hydroxy-1-phenylethyl]amino]-1-oxopropyl]pyrrolidine |
491833-26-2 |
Eliglustat intermediate |
| (1R,2R)-2-Amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol |
491833-28-4 |
Eliglustat intermediate |
| 2,5-Dioxopyrrolidin-1-yl octanoate |
14464-30-3 |
Eliglustat intermediate |
| Eliglustat |
491833-29-5 |
Eliglustat |
| Eliglustat tartrate |
928659-70-5 |
Eliglustat tartrate |
| (S)-1-(5-PHENYL-1H-IMIDAZOL-2-YL)ETHANAMINE |
864825-23-0 |
Eluxadoline intermediate |
| Methyl 5-formyl-2-methoxybenzoate |
78515-16-9 |
Eluxadoline intermediate |
| 4-(Aminocarbonyl)-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-L-phenylalanine |
623950-02-7 |
Eluxadoline intermediate |
| Eluxadoline |
864821-90-9 |
Eluxadoline |
| Eluxadoline Dihydrochloride |
864825-13-8 |
Eluxadoline Dihydrochloride |
| Thiomorpholine-1,1-dioxide |
39093-93-1 |
Filgotinib intermidate |
| Thiomorpholine-1,1-dioxide hydrochloride |
59801-62-6 |
Filgotinib intermediate |
| 5-Chloro[1,2,4]triazolo[1,5-a]pyridin-2-amine |
175965-64-7 |
Filgotinib intermidate |
| 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine |
1010120-55-4 |
Filgotinib intermidate |
| N-(5-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
1142943-96-1 |
Filgotinib intermidate |
| Filgotinib |
1206161-97-8 |
Filgotinib |
| Filgotinib maleate |
1802998-75-9 |
Filgotinib maleate |
| 1 ,3-dimethyl adamantane |
702-79-4 |
Memantine intermediate |
| 1-Bromo-3,5-dimethyladamantane |
941-37-7 |
Memantine intermediate |
| Memantine HCI |
41100-52-1 |
Memantine HCI |
| Imidazo[1,2-a]pyridin-3-ylacetic acid |
17745-04-9 |
Minodronic acid intermidate |
| Ethyl (E)-4,4-dimethoxy-2-butenoate |
114736-25-3 |
Minodronic acid intermediate |
| Minodronic acid |
180064-38-4 |
Minodronic acid |
| 4-Nitrophenethylamine hydrochloride |
29968-78-3 |
Mirabegron intermediate |
| (alphaR)-alpha-[[[2-(4-Nitrophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride |
521284-21-9 |
Mirabegron intermediate |
| (alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride |
521284-22-0 |
Mirabegron intermediate |
| 2-Aminothiazol-4-acetic acid |
29676-71-9 |
Mirabegron intermediate |
| Mirabegron |
223673-61-8 |
Mirabegron |
| N-Ethyl-N-methyl carbamoyl chloride |
42252-34-6 |
Rivastigmine intermediate |
| 3-(1-(dimethylamino)ethyl)phenol |
105601-04-5 |
Rivastigmine intermediate |
| (S)-3-(1-(dimethylamino)ethyl)phenol |
139306-10-8 |
Rivastigmine intermediate |
| Rivastigmine |
123441-03-2 |
Rivastigmine |
| Rivastigmine tartrate |
129101-54-8 |
Rivastigmine tartrate |
| 4-Amino-3-hydroxybenzoic acid |
2374-03-0 |
Tafamidis intermediate |
| 3,5-Dichlorobenzoyl chloride |
2905-62-6 |
Tafamidis intermediate |
| 3,5-Dichlorobenzoic acid |
51-36-5 |
Tafamidis intermediate |
| Tafamidis |
594839-88-0 |
Tafamidis |
| Tafamidis meglumine |
951395-08-7 |
Tafamidis meglumine |
| 2,4-Dichloro-1H-pyrrolo[2,3-d]pyrimidine |
90213-66-4 |
Tofacitinib intermediate |
| N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride (1:2) |
1228879-37-5 |
Tofacitinib intermediate |
| (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine |
477600-70-7 |
Tofacitinib intermediate |
| (3R,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride |
1062580-52-2 |
Tofacitinib intermediate |
| (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]butanedioic acid compd. with (3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine |
477600-71-8 |
Tofacitinib intermidate |
| N-Methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
477600-73-0 |
Tofacitinib intermediate |
| cis-1-Benzyl-N-methyl-4-methylpiperidin-3-amine dihydrochloride |
477600-68-3 |
|
| N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (N-1 BASE) |
477600-74-1 |
Tofacitinib intermediate |
| N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-amine dihydrochloride (N-1 HCl) |
1260590-51-9 |
Tofacitinib intermediate |
| Tofacitinib BASE |
477600-75-2 |
Tofacitinib BASE |
| Tofacitinib Citratet |
540737-29-9 |
Tofacitinib Citratet |
| 2,6-Dichlorobenzyl bromide |
20443-98-5 |
Vilanterol intermidate |
| 2-bromo-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-Ethanone |
102293-80-1 |
Vilanterol intermidate |
| tert-butyl 2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-oxoethylcarbamate |
452339-71-8 |
Vilanterol intermidate |
| tert-butyl (2R)-2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethylcarbamate |
452339-72-9 |
Vilanterol intermidate |
| 5-(2,2-diMethyl-4H-benzo[d][1,3]dioxin-6-yl)oxazolidin-2-one |
452340-96-4 |
Vilanterol intermidate |
| (5R)-5-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one |
452339-73-0 |
Vilanterol intermidate |
| 2-[(2,6-Dichlorophenyl)methoxy]-ethanol |
85309-91-7 |
Vilanterol intermidate |
| Benzene, 2-[[2-[(6-broMohexyl)oxy]ethoxy]Methyl]-1,3-dichloro |
503070-57-3 |
Vilanterol intermidate |
| (5R)-3-[6-[2-[(2,6-dichlorophenyl)Methoxy]ethoxy]hexyl]-5-(2,2-diMethyl-4H-1, 3-benzodioxin-6-yl)-2-Oxazolidinone |
503068-36-8 |
Vilanterol intermidate |
| (1R)-2-[[6-[2-[(2,6-Dichlorobenzyl)oxy]ethoxy]hexyl]amino]-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol |
503068-37-9 |
Vilanterol intermidate |
| Triphenylacetic acid |
595-91-5 |
Vilanterol intermidate |
| Vilanterol |
503068-34-6 |
Vilanterol |
| Vilanterol Trifenate |
503070-58-4 |
Vilanterol Trifenate |
中文 
English
